Congenital chylothorax: a prospective nationwide epidemiological study in Germany

Abstract

Based on this small observational study, CCT seems to have a favourable prognosis if not associated with genetic disorders.

Effects of somatostatin/octreotide treatment in neonates with congenital chylothorax

“…However, this incidence is not based on general population, but on the number of admissions; therefore, it is reasonable to consider that this incidence is higher than that reported by previous studies (1:5800–1:24000). [1,2] Other possible underlying reasons include different races and referral bias, as our neonatal center is 1 of the biggest territory referral site within China. The incidence of a delivered newborn to be transferred into a neonatal department after birth is around 3% to 5% per year in China.…”

“…The reported incidence of congenital chylothorax is about 1:5800 to 1:24000 [1,2] in live-born neonates. Once the diagnosis is confirmed, the first-line management is dietary modification, which ranges from aggressive fasting with total parenteral nutrition to median chain triglyceride (MCT)-enriched formula, and eventually normal feeding.…”

G215(P) Identifying facial features associated with prenatal alcohol exposure in newborn infants using 2D and 3D imaging

“…Total patient Seizure resolution Aim Neonatal chylothorax is a rare condition with an incidence of 1 in 5775 [1] to 24000 [2] and has a high mortality rate of up to 64% [2]. Our aim was to create a pathway for the diagnosis and management of neonatal chylothorax based on experience in a tertiary neonatal referral centre and a review of the literature.…”

G217(P) Neonatal chylothorax: a pathway based on a literature review and ten years experience in a tertiary neonatal referral centre

“…Levetiracetam was not started on one baby who had a diagnosis of pyridoxine-dependent seizure and this baby responded well to pyridoxine. 30 babies treated with Levetiracetam seizure control attained soon after its use in 24 babies (80% Aim Neonatal chylothorax is a rare condition with an incidence of 1 in 5775 [1] to 24000 [2] and has a high mortality rate of up to 64% [2]. Our aim was to create a pathway for the diagnosis and management of neonatal chylothorax based on experience in a tertiary neonatal referral centre and a review of the literature.…”